Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 1Phase 2 1

Status

Completed 6

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Interventional 6Observational 1

Sponsor

Conditions

Dupuytren Contracture 6Contracture 2

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × xiapex × Clear all
NCT01407068 2017-10-05

Administration of Two Injections for Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
60 enrolled 12 charts

Dupuytren Contracture

NCT01498640 2017-10-05

Retreatment of Recurrent Dupuytren's Contractures

Endo Pharmaceuticals

Phase 4 Completed
52 enrolled 15 charts

Contracture, Dupuytren Contracture

NCT01674634 2017-10-05

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
715 enrolled 17 charts

Contracture, Dupuytren Contracture

NCT02193828 2017-10-05

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Endo Pharmaceuticals

Phase 2 Completed
76 enrolled 17 charts

Dupuytren Contracture

NCT01588353 2017-03-21

CORD-J

Asahi Kasei Therapeutics Corporation

Phase 3 Completed
104 enrolled 13 charts

Dupuytren Contracture

NCT01229436 2014-03-17

POINT X

Pfizer

Phase 3 Completed
254 enrolled 28 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡